PHMMF
Price:
$92.57
Market Cap:
$1.39B
Pharma Mar, S.A., a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles of marine origin for use in oncology in Spain, Italy, Germany, Ireland, rest of EU, the United States, and internationally. The company operates through three segments: Oncology, Diagnostics, and RNA interference. It develops and commercializes Yondelis for the treatment of soft tissue sarcomas and for ovarian cancer; Aplidin for treating multiple myeloma; and Zepzelca for treating patients with small cell lung cancer. The company also develops PM14 which is in phase II clinical trails for the treatment of solid tumors. In addition, it develops and m...[Read more]
Industry
Biotechnology
IPO Date
2016-02-23
Stock Exchange
OTC
Ticker
PHMMF
According to Pharma Mar, S.A.’s latest financial reports and current stock price. The company's current Current Ratio is 2.97. This represents a change of 5.97% compared to the average of 2.80 of the last 4 quarters.
The mean historical Current Ratio of Pharma Mar, S.A. over the last ten years is 2.05. The current 2.97 Current Ratio has changed 14.41% with respect to the historical average. Over the past ten years (40 quarters), PHMMF's Current Ratio was at its highest in in the March 2022 quarter at 3.59. The Current Ratio was at its lowest in in the March 2019 quarter at 0.58.
Average
2.05
Median
2.09
Minimum
0.83
Maximum
3.42
Discovering the peaks and valleys of Pharma Mar, S.A. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 212.98%
Maximum Annual Current Ratio = 3.42
Minimum Annual Increase = -20.31%
Minimum Annual Current Ratio = 0.83
Year | Current Ratio | Change |
---|---|---|
2024 | 3.03 | 14.87% |
2023 | 2.63 | -6.83% |
2022 | 2.83 | -17.30% |
2021 | 3.42 | 32.12% |
2020 | 2.59 | 212.98% |
2019 | 0.83 | -20.31% |
2018 | 1.04 | -7.44% |
2017 | 1.12 | -19.23% |
2016 | 1.39 | -12.58% |
2015 | 1.59 | 28.73% |
The current Current Ratio of Pharma Mar, S.A. (PHMMF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
2.83
5-year avg
2.90
10-year avg
2.05
Pharma Mar, S.A.’s Current Ratio is
Company | Current Ratio | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pharma Mar, S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Pharma Mar, S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Pharma Mar, S.A.'s Current Ratio?
How is the Current Ratio calculated for Pharma Mar, S.A. (PHMMF)?
What is the highest Current Ratio for Pharma Mar, S.A. (PHMMF)?
What is the 3-year average Current Ratio for Pharma Mar, S.A. (PHMMF)?
What is the 5-year average Current Ratio for Pharma Mar, S.A. (PHMMF)?
How does the current Current Ratio for Pharma Mar, S.A. (PHMMF) compare to its historical average?